Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Oxytocin receptors are found in skin cells near touch and pain neurons.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.